MX2024003006A - Sistemas, composiciones y metodos que implican retrotransposones y fragmentos funcionales de estos. - Google Patents
Sistemas, composiciones y metodos que implican retrotransposones y fragmentos funcionales de estos.Info
- Publication number
- MX2024003006A MX2024003006A MX2024003006A MX2024003006A MX2024003006A MX 2024003006 A MX2024003006 A MX 2024003006A MX 2024003006 A MX2024003006 A MX 2024003006A MX 2024003006 A MX2024003006 A MX 2024003006A MX 2024003006 A MX2024003006 A MX 2024003006A
- Authority
- MX
- Mexico
- Prior art keywords
- systems
- functional fragments
- retrotransposons
- compositions
- cargo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1247—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
- C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/18011—Details ssRNA Bacteriophages positive-sense
- C12N2795/18111—Leviviridae
- C12N2795/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/40—Systems of functionally co-operating vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163241943P | 2021-09-08 | 2021-09-08 | |
| PCT/US2022/076061 WO2023039438A1 (en) | 2021-09-08 | 2022-09-07 | Systems, compositions, and methods involving retrotransposons and functional fragments thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024003006A true MX2024003006A (es) | 2024-03-25 |
Family
ID=85506902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024003006A MX2024003006A (es) | 2021-09-08 | 2022-09-07 | Sistemas, composiciones y metodos que implican retrotransposones y fragmentos funcionales de estos. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240287484A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4399299A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534856A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240051994A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118076731A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022343719A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230213A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024003006A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023039438A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026514069A (ja) * | 2023-04-11 | 2026-05-01 | ベイジン・アストラジェノミクス・テクノロジー・カンパニー,リミテッド | 非ltrレトロトランスポゾンシステム及びその使用 |
| WO2025199534A1 (en) * | 2024-03-22 | 2025-09-25 | Typewriter Therapeutics, Inc. | New r2 retrotransposons for gene writing |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019327449B2 (en) * | 2018-08-28 | 2026-04-09 | Flagship Pioneering Innovations Vi, Llc | Methods and compositions for modulating a genome |
| US20220298495A1 (en) * | 2019-06-12 | 2022-09-22 | Emendobio Inc. | Novel genome editing tool |
| WO2021046243A2 (en) * | 2019-09-03 | 2021-03-11 | Myeloid Therapeutics, Inc. | Methods and compositions for genomic integration |
-
2022
- 2022-09-07 KR KR1020247009394A patent/KR20240051994A/ko active Pending
- 2022-09-07 JP JP2024513336A patent/JP2024534856A/ja active Pending
- 2022-09-07 CA CA3230213A patent/CA3230213A1/en active Pending
- 2022-09-07 CN CN202280062406.5A patent/CN118076731A/zh active Pending
- 2022-09-07 WO PCT/US2022/076061 patent/WO2023039438A1/en not_active Ceased
- 2022-09-07 EP EP22868284.5A patent/EP4399299A4/en not_active Withdrawn
- 2022-09-07 AU AU2022343719A patent/AU2022343719A1/en not_active Abandoned
- 2022-09-07 MX MX2024003006A patent/MX2024003006A/es unknown
-
2024
- 2024-03-07 US US18/598,627 patent/US20240287484A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3230213A1 (en) | 2023-03-16 |
| KR20240051994A (ko) | 2024-04-22 |
| WO2023039438A1 (en) | 2023-03-16 |
| EP4399299A1 (en) | 2024-07-17 |
| CN118076731A (zh) | 2024-05-24 |
| US20240287484A1 (en) | 2024-08-29 |
| AU2022343719A1 (en) | 2024-04-11 |
| EP4399299A4 (en) | 2025-09-03 |
| JP2024534856A (ja) | 2024-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021006844A8 (pt) | Métodos para editar um rna alvo e para tratar ou prevenir uma doença ou condição, rna editado ou uma célula hospedeira tendo um rna editado, rna que recruta desaminase, construção, biblioteca, composição, célula hospedeira, e, kit para editar um rna alvo . | |
| MX2022012677A (es) | Compuestos y metodos para modular el empalme. | |
| MX2022009707A (es) | Vacunas de dominio de arnm contra el sars-cov-2. | |
| BR112023023527A2 (pt) | Inibidores de nlrp3 | |
| CL2020003269A1 (es) | Composición para pozos | |
| NO20081907L (no) | Forsinkede hydrokarbongelfornettere og fremgangsmater for fremstilling og anvendelse av disse | |
| CO2017011810A2 (es) | Composiciones termalmente estables e inhibidoras de residuos | |
| CL2017002514A1 (es) | Anticuerpos anti-c1s humanizados y métodos para usarlos. | |
| BRPI0720525B8 (pt) | inibidores de mapk/erk quinase | |
| BR112015026847A2 (pt) | tiazóis e usos dos mesmos | |
| BR112018071979A2 (pt) | óxidos misturados à base de cério e zircônio | |
| BR112022011426A2 (pt) | Uso de inibidores de atr em combinação com inibidores de parp | |
| MX2022014853A (es) | Mezcla de biocementacion para el control del polvo y aplicaciones relacionadas. | |
| CO2024015896A2 (es) | Inhibidores de mek y usos de estos | |
| MX2017003226A (es) | Metodos de cementacion de aluminato de calcio con vida util prolongada. | |
| CO2023012342A2 (es) | Inhibidores de enzimas | |
| MX2024008413A (es) | Compuestos macrocíclicos y uso como inhibidores de cinasas. | |
| MX2021014672A (es) | Uso de un aglutinante hidraulico que contiene aluminato de calcio para la produccion de un material de construccion. | |
| MX2017016373A (es) | Composiciones de cemento de aluminofosfato de calcio con vida util prolongada. | |
| BR112015022555A2 (pt) | métodos de detecção de uma primeira planta, de melhoramento de plantas de soja e para prolongar a duração de um estágio de desenvolvimento reprodutivo | |
| MX2024010279A (es) | Proteinas de fusion | |
| BR112016023822B8 (pt) | Método e composição de inibição de corrosão | |
| MX2025013050A (es) | Composicion, metodos y usos | |
| ECSP24016777A (es) | Compuestos y métodos para modular el empalme | |
| CO2024002648A2 (es) | Compuestos y métodos para modular splicing |